The Curbsiders Internal Medicine Podcast#526 DIGEST – game changers in pancreatic cancer, lipid guideline updates, and GLP-1/GIP endoscopy holds

Pancreatic Drug Doubles Survival

20:17–21:53 · 95s

Nora previews phase-3 data on diraxsonricib, a KRAS inhibitor that almost doubles overall survival in previously treated metastatic pancreatic cancer—big news headed to ASCO.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.